Zhencheng Wang

High‐dose dexamethasone plus recombinant human thrombopoietin vs high‐dose dexamethasone alone as frontline treatment for newly diagnosed adult primary immune thrombocytopenia: A prospective, multicenter, randomized trial

Hong-guo Zhao, Xin Wang, M. Hou, 2020, American journal of hematology.

Dexamethasone plus oseltamivir versus dexamethasone in treatment-naive primary immune thrombocytopenia: a multicentre, randomised, open-label, phase 2 trial.

Hong-guo Zhao, M. Hou, Yu Hou, 2021, The Lancet. Haematology.

A prospective, multicenter study of low dose decitabine in adult patients with refractory immune thrombocytopenia

Xin Wang, M. Hou, Yu Hou, 2019, American journal of hematology.

[Prospective multicentre study of chemotherapeutic regimen containing pirarubicin on the treatment of relapsed or refractory acute myeloid leukemia in adults].

Hong-guo Zhao, Sheng Yang, M. Hou, 2014, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.

High-Dose Dexamethasone (HD-DXM) Plus Oseltamivir Versus High-Dose Dexamethasone for Treatment of Adult Primary Immune Thrombocytopenia: Interim Analysis of a Prospective, Multicenter, Randomized, Controlled Trial

Hong-guo Zhao, M. Hou, Yu Hou, 2019, Blood.